MANNKIND CORP Operating Expenses
MANNKIND CORP (MNKD) reported Operating Expenses of $29.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-05
- MANNKIND CORP operating expenses for the quarter ending 2026-06-30 was $29.54M, a 43.62% increase year-over-year.
- MANNKIND CORP operating expenses for the quarter ending 2025-06-30 was $20.57M, a 0.94% increase year-over-year.
- MANNKIND CORP operating expenses for the quarter ending 2024-12-31 was $19.60M, a 8.51% increase year-over-year.
- MANNKIND CORP operating expenses for the quarter ending 2024-09-30 was $18.02M, a 26.44% increase year-over-year.
- MANNKIND CORP operating expenses for fiscal 2025 was $87.96M, a 14.83% increase from fiscal 2024.
- MANNKIND CORP operating expenses for fiscal 2024 was $76.60M, a 22.03% increase from fiscal 2023.
- MANNKIND CORP operating expenses for fiscal 2023 was $62.77M, a 9.17% increase from fiscal 2022.
- MANNKIND CORP operating expenses for fiscal 2022 was $57.50M, a 47.97% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 244 month | Operating Expenses 247 month | Operating Expenses 250 month | Operating Expenses 253 month | Operating Expenses 256 month | Operating Expenses 259 month | Operating Expenses 263 month | Operating Expenses 265 month | Operating Expenses 268 month | Operating Expenses 271 month | Operating Expenses 275 month | Operating Expenses 277 month | Operating Expenses 280 month | Operating Expenses 283 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $29.54M 10-Q · filed 2026-08-05 | $47.01M 10-Q · filed 2026-08-05 | ||||||||||||||||
| 2025-12-31 | $87.96M 10-K · filed 2026-02-26 | |||||||||||||||||
| 2025-06-30 | $20.57M 10-Q · filed 2026-08-05 | $38.08M 10-Q · filed 2026-08-05 | ||||||||||||||||
| 2024-12-31 | $19.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $37.63M derived: sum of 2 quarters · filed 2026-02-26 | $58.00M derived: sum of 3 quarters · filed 2026-02-26 | $76.60M 10-K · filed 2026-02-26 | ||||||||||||||
| 2024-09-30 | $18.02M 10-Q · filed 2024-11-07 | $38.40M derived: sum of 2 quarters · filed 2024-11-07 | $57.00M 10-Q · filed 2024-11-07 | $75.06M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||
| 2024-06-30 | $20.38M 10-Q · filed 2024-08-07 | $38.98M 10-Q · filed 2024-08-07 | $57.04M derived: sum of 3 quarters · filed 2026-02-26 | $71.30M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||
| 2024-03-31 | $18.60M 10-Q · filed 2024-05-08 | $36.66M derived: sum of 2 quarters · filed 2026-02-26 | $50.92M derived: sum of 3 quarters · filed 2026-02-26 | $65.16M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||
| 2023-12-31 | $18.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $32.32M derived: sum of 2 quarters · filed 2026-02-26 | $46.56M derived: sum of 3 quarters · filed 2026-02-26 | $62.77M 10-K · filed 2026-02-26 | ||||||||||||||
| 2023-09-30 | $14.25M 10-Q · filed 2024-11-07 | $28.49M derived: sum of 2 quarters · filed 2024-11-07 | $44.70M 10-Q · filed 2024-11-07 | $60.83M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||||||||
| 2023-06-30 | $14.24M 10-Q · filed 2024-08-07 | $30.45M 10-Q · filed 2024-08-07 | $46.57M derived: sum of 3 quarters · filed 2025-02-26 | $64.03M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||||||||
| 2023-03-31 | $16.21M 10-Q · filed 2024-05-08 | $32.34M derived: sum of 2 quarters · filed 2025-02-26 | $49.80M derived: sum of 3 quarters · filed 2025-02-26 | $62.71M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||||||||
| 2022-12-31 | $16.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $33.58M derived: sum of 2 quarters · filed 2025-02-26 | $46.50M derived: sum of 3 quarters · filed 2025-02-26 | $57.50M 10-K · filed 2025-02-26 | ||||||||||||||
| 2022-09-30 | $17.46M 10-Q · filed 2023-11-07 | $30.38M derived: sum of 2 quarters · filed 2023-11-07 | $41.37M 10-Q · filed 2023-11-07 | $52.81M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||
| 2022-06-30 | $12.91M 10-Q · filed 2023-08-07 | $23.91M 10-Q · filed 2023-08-07 | $35.35M derived: sum of 3 quarters · filed 2024-02-27 | $45.23M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||
| 2022-03-31 | $11.00M 10-Q · filed 2023-05-09 | $22.43M derived: sum of 2 quarters · filed 2024-02-27 | $32.32M derived: sum of 3 quarters · filed 2024-02-27 | $42.24M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||
| 2021-12-31 | $11.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $21.32M derived: sum of 2 quarters · filed 2024-02-27 | $31.25M derived: sum of 3 quarters · filed 2024-02-27 | $38.86M 10-K · filed 2024-02-27 | ||||||||||||||
| 2021-09-30 | $9.89M 10-Q · filed 2022-11-08 | $19.81M derived: sum of 2 quarters · filed 2022-11-08 | $27.42M 10-Q · filed 2022-11-08 | |||||||||||||||
| 2021-06-30 | $9.93M 10-Q · filed 2022-08-09 | $17.54M 10-Q · filed 2022-08-09 | ||||||||||||||||
| 2020-12-31 | $24.64M 10-K · filed 2023-02-23 | |||||||||||||||||
| 2016-03-31 | $20.01M 10-Q · filed 2016-05-09 | $292.88M derived: sum of 2 quarters · filed 2016-05-09 | $318.88M derived: sum of 3 quarters · filed 2016-05-09 | $342.93M derived: sum of 4 quarters · filed 2016-05-09 | ||||||||||||||
| 2015-12-31 | $272.86M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $298.87M derived: sum of 2 quarters · filed 2016-03-15 | $322.92M derived: sum of 3 quarters · filed 2016-03-15 | $344.65M 10-K · filed 2016-03-15 | ||||||||||||||
| 2015-09-30 | $26.00M 10-Q · filed 2015-11-09 | $50.05M derived: sum of 2 quarters · filed 2015-11-09 | $71.79M 10-Q · filed 2015-11-09 | $101.89M derived: sum of 4 quarters · filed 2016-05-09 | ||||||||||||||
| 2015-06-30 | $24.05M 10-Q · filed 2015-08-10 | $45.79M 10-Q · filed 2015-08-10 | $75.89M derived: sum of 3 quarters · filed 2016-05-09 | $114.16M derived: sum of 4 quarters · filed 2016-05-09 | ||||||||||||||
| 2015-03-31 | $21.74M 10-Q · filed 2016-05-09 | $51.84M derived: sum of 2 quarters · filed 2016-05-09 | $90.11M derived: sum of 3 quarters · filed 2016-05-09 | $159.95M derived: sum of 4 quarters · filed 2016-05-09 | ||||||||||||||
| 2014-12-31 | $30.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $68.37M derived: sum of 2 quarters · filed 2016-03-15 | $138.22M derived: sum of 3 quarters · filed 2016-03-15 | $179.63M 10-K · filed 2016-03-15 | ||||||||||||||
| 2014-09-30 | $38.27M 10-Q · filed 2015-11-09 | $108.11M derived: sum of 2 quarters · filed 2015-11-09 | $149.52M 10-Q · filed 2015-11-09 | $196.14M derived: sum of 4 quarters · filed 2016-03-15 | $2.38B 10-Q · filed 2014-11-10 | |||||||||||||
| 2014-06-30 | $69.85M 10-Q · filed 2015-08-10 | $111.26M 10-Q · filed 2015-08-10 | $157.87M derived: sum of 3 quarters · filed 2016-03-15 | $202.64M derived: sum of 4 quarters · filed 2016-03-15 | $2.35B 10-Q · filed 2014-08-11 | |||||||||||||
| 2014-03-31 | $41.41M 10-Q · filed 2015-05-11 | $88.03M derived: sum of 2 quarters · filed 2016-03-15 | $132.79M derived: sum of 3 quarters · filed 2016-03-15 | $174.38M derived: sum of 4 quarters · filed 2016-03-15 | $2.28B 10-Q · filed 2014-05-12 | |||||||||||||
| 2013-12-31 | $46.62M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $91.38M derived: sum of 2 quarters · filed 2016-03-15 | $132.96M derived: sum of 3 quarters · filed 2016-03-15 | $169.40M 10-K · filed 2016-03-15 | $2.23B 10-K · filed 2014-03-03 | |||||||||||||
| 2013-09-30 | $44.76M 10-Q · filed 2014-11-10 | $86.35M derived: sum of 2 quarters · filed 2014-11-10 | $122.78M 10-Q · filed 2014-11-10 | $156.27M derived: sum of 4 quarters · filed 2015-03-02 | $2.19B 10-Q · filed 2013-11-12 | |||||||||||||
| 2013-06-30 | $41.59M 10-Q · filed 2014-08-11 | $78.02M 10-Q · filed 2014-08-11 | $111.51M derived: sum of 3 quarters · filed 2015-03-02 | $147.03M derived: sum of 4 quarters · filed 2015-03-02 | $2.14B 10-Q · filed 2013-08-09 | |||||||||||||
| 2013-03-31 | $36.44M 10-Q · filed 2014-05-12 | $69.92M derived: sum of 2 quarters · filed 2015-03-02 | $105.44M derived: sum of 3 quarters · filed 2015-03-02 | $149.50M derived: sum of 4 quarters · filed 2015-03-02 | $2.10B 10-Q · filed 2013-05-10 | |||||||||||||
| 2012-12-31 | $33.49M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $69.01M derived: sum of 2 quarters · filed 2015-03-02 | $113.06M derived: sum of 3 quarters · filed 2015-03-02 | $147.00M 10-K · filed 2015-03-02 | $2.06B 10-K · filed 2013-03-18 | |||||||||||||
| 2012-09-30 | $35.52M 10-Q · filed 2013-11-12 | $79.58M derived: sum of 2 quarters · filed 2013-11-12 | $113.51M 10-Q · filed 2013-11-12 | $144.09M derived: sum of 4 quarters · filed 2014-03-03 | $2.03B 10-Q · filed 2012-11-09 | |||||||||||||
| 2012-06-30 | $44.05M 10-Q · filed 2013-08-09 | $77.99M 10-Q · filed 2013-08-09 | $108.57M derived: sum of 3 quarters · filed 2014-03-03 | $141.34M derived: sum of 4 quarters · filed 2014-03-03 | $2.00B 10-Q · filed 2012-08-09 | |||||||||||||
| 2012-03-31 | $33.93M 10-Q · filed 2013-05-10 | $64.51M derived: sum of 2 quarters · filed 2014-03-03 | $97.28M derived: sum of 3 quarters · filed 2014-03-03 | $136.47M derived: sum of 4 quarters · filed 2014-03-03 | $1.95B 10-Q · filed 2012-05-10 | |||||||||||||
| 2011-12-31 | $30.58M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $63.35M derived: sum of 2 quarters · filed 2014-03-03 | $102.54M derived: sum of 3 quarters · filed 2014-03-03 | $140.59M 10-K · filed 2014-03-03 | $1.92B 10-K · filed 2012-03-15 | |||||||||||||
| 2011-09-30 | $32.77M 10-Q · filed 2012-11-09 | $71.96M derived: sum of 2 quarters · filed 2012-11-09 | $110.01M 10-Q · filed 2012-11-09 | $142.10M derived: sum of 4 quarters · filed 2013-03-18 | $1.89B 10-Q · filed 2011-11-04 | |||||||||||||
| 2011-06-30 | $39.19M 10-Q · filed 2012-08-09 | $77.24M 10-Q · filed 2012-08-09 | $109.33M derived: sum of 3 quarters · filed 2013-03-18 | $151.87M derived: sum of 4 quarters · filed 2013-03-18 | $1.85B 10-Q · filed 2011-08-04 | |||||||||||||
| 2011-03-31 | $38.05M 10-Q · filed 2012-05-10 | $70.14M derived: sum of 2 quarters · filed 2013-03-18 | $112.68M derived: sum of 3 quarters · filed 2013-03-18 | $150.04M derived: sum of 4 quarters · filed 2013-03-18 | ||||||||||||||
| 2010-12-31 | $32.09M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $74.63M derived: sum of 2 quarters · filed 2013-03-18 | $111.99M derived: sum of 3 quarters · filed 2013-03-18 | $152.59M 10-K · filed 2013-03-18 | ||||||||||||||
| 2010-09-30 | $42.54M 10-Q · filed 2011-11-04 | $79.90M derived: sum of 2 quarters · filed 2011-11-04 | $120.50M 10-Q · filed 2011-11-04 | |||||||||||||||
| 2010-06-30 | $37.36M 10-Q · filed 2011-08-04 | $77.96M 10-Q · filed 2011-08-04 | ||||||||||||||||
| 2009-12-31 | $209.78M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |